Cargando…
Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria
The increasing rate of antibiotic resistance constitutes a global health crisis. Antimicrobial peptides (AMPs) have the property to selectively kill bacteria regardless of resistance to traditional antibiotics. However, several challenges (e.g., reduced activity in the presence of serum and lack of...
Autores principales: | Deslouches, Berthony, Montelaro, Ronald C., Urish, Ken L., Di, Yuanpu P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357155/ https://www.ncbi.nlm.nih.gov/pubmed/32486228 http://dx.doi.org/10.3390/pharmaceutics12060501 |
Ejemplares similares
-
Elimination of Antibiotic Resistant Surgical Implant Biofilms Using an Engineered Cationic Amphipathic Peptide WLBU2
por: Mandell, Jonathan B., et al.
Publicado: (2017) -
Simultaneous Antibiofilm and Antiviral Activities of an Engineered Antimicrobial Peptide during Virus-Bacterium Coinfection
por: Melvin, Jeffrey A., et al.
Publicado: (2016) -
Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria
por: Di, Y. P., et al.
Publicado: (2020) -
Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications
por: Deslouches, Berthony, et al.
Publicado: (2017) -
Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections
por: Deslouches, Berthony, et al.
Publicado: (2017)